Skip to main content
MolecuLight LogoStart Seeing Wounds in a New Light ™
Start Seeing Wounds in a New Light ™
    • MolecuLight Logo
    • Solutions
        Solutions
        The MolecuLight i:X and DX for point-of-care detection of elevated bacterial burden in wounds – in real-time

        • MolecuLightDX  
        • MolecuLight i:X  
        • Intro to the i:X
        • How does Fluorescence Imaging Work
        • Detection of Bacterial Burden
        • Digital Wound Area Measurement
        • EMR Integration
        • Telemedicine Solution
        • MolecuLight Procedure
        • i:X Workflow
        • Image Interpretation
        • Preview the MolecuLight i:X
        • Intro to the i:X Workflow
        • Image Atlas
        • Product Suite
        • MolecuLightDX Device
        • MolecuLight i:X Device
        • Accessories
          •   DarkDrape
          •   WoundStickers
          •   i:X Sterile Surgical Sleeve
    • Wound Care Professionals
        Wound Care Professionals
        Research has shown how use of the MolecuLight i:X can inform clinical decision-making to improve wound healing rates

        • Cost Savings  
        • Improved Outcomes  
        • Reimbursement  
        • Training & Education  
        • eLearning
        • DX Training Videos
        • i:X Training Videos
        • Manuals & Quick Start Guide
        • Continuing Medical Education  
        • Clinical Research  
    • Patients
    • Resources
        Resources
        See the latest publication on how use of MolecuLight i:X can inform clinical decision-making to improve wound healing rates

        • Latest Clinical Evidence  
        • All Evidence
          •   Accelerated Wound Healing
          •   Acute Wounds
          •   Advanced Therapies
          •   Anti-Microbial Stewardship
          •   Species Detected/Biofilm
          •   Burns
          •   Chronic Wounds
        •  
          •   Cost-Savings/ Reimbursement
          •   Detection of Bacterial Burden
          •   Diagnostic Accuracy
          •   Digital Wound Measurement
          •   Debridement/Wound Hygiene
          •   Pre-Clinical Applications
          •   Treatment Planning
          •   Wound Sampling
        • Webcasts  
        • Video Master Series  
        • Image Atlas  
        • Training & Education
        • eLearning
        • DX Training Videos
        • i:X Training Videos
        • Manuals & Quick Start Guide
    • About Us
        About Us
        See the latest press releases, events and updates from MolecuLight

        • About MolecuLight  
        • Management Team  
        • Press Releases  
        • Conferences & Events  
        • Careers  
        • Contact MolecuLight  
        • Distributors  
    • Request A Demo
Contact Us
Contact Us
Get in touch with MolecuLight or directly with our Global Distributors.
  • Contact MolecuLight  
  • Distributors  
  • Quick links:
  • MolecuLight i:X
  • Digital Measurement of Wound Area
  • Latest Clinical Evidence
  • Latest news
Phone: +1-877-818-4360
Non-US US
ROW

DFU_0045_FL_RR_IMG_2473_CS-Fig6

July 14, 2018 -Figure 6: FL-image Wound debrided under MolecuLight i:X guidance until red fluorescing bacteria were no longer detected Read More

VLU_0017_ST_RR_IMG_1166_CS-Fig1

July 14, 2018 -PLACEHOLDER IMAGE Read More

VLU_0018_WM_RR_IMG_0489_CS-Fig1

July 14, 2018 -Figure 1: ST-image Image taken under standard lighting conditions with MolecuLight WoundStickers Read More

VLU_0018_ST_RR_IMG_0490_CS-Fig2

July 14, 2018 -Figure 2: ST-image, wound measurement Clinician used Manual Trace to capture the wound border Read More

VLU_0047_ST_RH_IMG_0388_CS-Fig1

July 14, 2018 -Figure 1: ST-image Read More

VLU_0047_FL_RH_IMG_0384_CS-Fig2

July 14, 2018 -Figure 2: FL-image Arrows indicate regions of cyan fluorescence Swabs of cyan regions later confirmed to be moderate growth of P. aeruginosa Read More

DFU_0056_ST_DR_IMG_0286_CS-Fig1

July 14, 2018 -Figure 1: ST-image Diabetic foot ulcer with significant deterioration (3x area increase over 4 weeks) Read More

DFU_0056_ST_DR_IMG_0302_CS-Fig2

July 14, 2018 -Figure 3: ST-image After 2 weeks, wound area had decreased by 45% Read More

DFU_0056_FL_DR_IMG_0285_CS-Fig3

July 14, 2018 -Figure 2: FL-image FL-image revealed significant bioburden (red fluorescence) after debridement Read More

Previous
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 23
Next

Ready to see the difference?

MolecuLight i:X logo MolecuLight splitter MolecuLight DX logo
FDA and CE Cleared Logo

MolecuLight Headquarters

425 University Avenue
Suite 700
Toronto, ON  M5G 1T6
Canada

US Address
MolecuLight Corp.

2403 Sidney Street,
Suite 286
Pittsburgh, PA 15203

T. +1 647-362-4684
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com

Sitemap

  • MolecuLight DX Device
  • MolecuLight i:X
  • MolecuLight i:X Case Studies
  • Publications (OLD)
  • MolecuLight Posters
  • Clinical Image Gallery of Fluorescence Images
  • Reimbursement
  • Training Resources
  • Webcast Recordings
  • Wound Care VIDEO MASTER SERIES
  • MolecuLightDX Training Videos
  • User Documentation for the MolecuLight i:X
  • Frequently Asked Questions (FAQ)
  • MolecuLight Executive Team
  • MolecuLight Conferences & Events
  • MolecuLight Press Releases
  • Contact MolecuLight
  • Distributors
  • MolecuLight Careers

MolecuLight is SOC ll®
Type l Accredited:

MolecuLight awarded
Premier’s Technology
Breakthrough Designation

MolecuLight i:X
is designated as a:

MolecuLight included
in ISWCAP Consensus
Guidelines:

MolecuLight is a proud
corporate member of:

Global
USA
Non-US US
ROW

©2025
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.

Privacy Policy |  Terms of Use |  Software Privacy Policy